[Evaluation of clinical effectiveness of the use of enterosorbent enterosgel in patients with diabetes mellitus and suppurative-inflammatory lesions of soft tissues].
While complex application of "Enterosgel" preparation in 47 patients with diabetes mellitus the acceleration of disease compensation was noted, what permitted to lower the sugar-reducing preparations dosage. This correspondingly improved the cholesterol indexes in blood plasma, what have illustrated the detoxication processes in organism and softening of purulent-inflammatory processes.
Shumeĭko
I A
IA
D002784:Cholesterol / Q000097:blood; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy; D016061:Enterosorption / Q000379:methods*; D005782:Gels; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007249:Inflammation / Q000628:therapy*; D012828:Silicones; D016060:Sorption Detoxification; D013492:Suppuration / Q000628:therapy*
D005782:Gels; D007004:Hypoglycemic Agents; D012828:Silicones; C078211:polymethylsiloxane; D002784:Cholesterol
Otsinka klinichnoï efektyvnosti zastosuvannia enterosorbentu enterosgel' u khvorykh na tsukrovyĭ diabet z hniĭno-zapal'nym urazhenniam m'iakykh tkanyn.